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Abstract 
Proper treatment of municipal wastewater is important not only for prevention of 
eutrophication but also for public health concerns. One consideration for wastewater 
treatment is the presence of organisms carrying antibiotic resistance genes. If these 
organisms survive the wastewater treatment process and are released into the streams, 
they can pose significant risks to public health. In addition, their presence also raises 
concerns for lateral gene transfer events at the wastewater plant. The spread of antibiotic 
loci has a major impact in public health and clinical therapy because resistant organisms 
render conventional treatments of important illnesses difficult. Beta-lactam drugs are 
known to be the most prescribed antibiotics in United State for bacterial infections. 
However, their effectiveness is threatened by the spread ofbeta-lactamases, which 
produce products that destroy beta-lactam drugs. In this study, wastewater samples were 
taken at two stages - prior to primary treatment and right before release into the 
environment - for examination of the presence of 4 common variants of beta-lactamase 
using polymerase chain reactions . For comparison, freshwater samples from the stream 
both upstream and downstream of the wastewater efflux site were also collected and 
analyzed. Various DNA extraction methods were performed and compared for efficiency 
and quality. When combined with 1 6S rDNA control results, our data revealed that 3 of 
the 4 loci assayed were present in the influx wastewater sample but absent in both the 
efflux and stream water samples. This shows that for the sample we collected, the 
wastewater treatment process in the city of Charleston has reduced these antibiotic 
resistance loci to undetectable levels during the treatment process. Our data also showed 
that these resistant loci did not occur in untreated stream water. 
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Introduction 
The presence of pathogens in wastewater and environment increases the risk to 
both human and animal health in many ways. First, the presence of pathogens can cause 
illnesses to humans and animals. Second, some of the pathogens carry genetic resistance 
to antibiotics, and through lateral gene transfer processes, can spread the resistance to 
other strains if given the opportunity. Scientists began to pay attention to municipal, 
medical, industrial, and agricultural wastes as sources to detect the presence of antibiotic 
resistance loci (1 ). The spread of antibiotic resistance is a global health concern and 
impacts all countries; however, the impact would be more severe in developing countries 
with insufficient public health infrastructures to monitor and control for the spread of 
antibiotic resistance, and then to subsequently treat the infections. The spread of 
antibiotic resistant loci can be detected in many ways, including both molecular and 
culture-dependent methods. When the wastewater from local homes, businesses, and 
industrial facilities, which carries human gastrointestinal track microflora, drains toward 
the local wastewater treatment plant, it creates an environment where microbial samples 
likely to contain variants carrying antibiotic resistance genetic markers are exposed to 
non-resistant variants, thus enabling lateral gene transfer processes that help spread 
antibiotic resistance. Wastewater treatment plants and untreated water from local streams 
are most common places that may have combination of many different microorganisms 
which can be useful to identify resistant genes in vitro (2-4). This makes investigating 
the presence and prevalence of antibiotic resistance loci from wastewater samples an 
important step in monitoring the process of antibiotic resistance spreading (5) .  
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Wastewater treatment plant process 
Wastewater goes into a treatment process to ensure the removal of harmful 
bacterial strains that may cause diseases to humans and to purify the water to a quality 
that is suitable for release into the environment. In this process, microbial organisms are 
indispensable, because they consume the useable carbon, nitrogen, and other nutrients 
from the wastewater. The varying metabolic capacities from different microbes are 
employed at different stages of the process to achieve the final objective of purifying 
wastewater. 
At municipal wastewater treatment, wastewater flows through a network of pipes 
called collection system from local places. Wastewater travels through the pipes by 
gravity and sometimes pipes get too deep, which require a pumper lift station to move 
wastewater to a new section of pipes depending on gravity again (6). According to the US 
EPA (United States Environmental Protection Agency), there are about 800,000 miles of 
collection systems along with 500,000 miles of private laterals which connect properties 
to wastewater treatment plants. 
In general, wastewater treatment in most treatment plants begins as described in 
the following steps. In the first part of treatment, which is known as the head process, 
large debris, such as cans, rags, and other trash are removed through filtration. Within the 
head works is the grit removal chamber, which let the water flow slowly to keep organic 
matter like food or bacteria stuck to the bottom of the grit (7) . Most treatment plants have 
mechanical equipment to remove the settled matters for other processes. 
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After the grit removal chamber, wastewater flows into primary treatment tanks. 
The first step is a set of fine screens that can remove even smaller debris. The main goal 
of primary treatment is to separate water from large organic matters physically. 
The next stage of treatment is called primary clarification process. Wastewater 
flows through the center of the clarifier tank. Water sits there for one to two hours to 
ensure of the removal of the remaining solids from previous processes. Cleaner water 
flows over the clarifier as solids settle out. Then, a rotating arm breaks the solids from the 
bottom of the clarifier into a hopper in the center. The solids are removed from the 
bottom of the clarifier and travel through a pipe for bio-solids treatment process (7) . 
The secondary treatment starts after the receiving of water coming from clarifier 
tanks. This part of treatment removes nutrients such as carbon and nitrogen to ensure that 
the water being released back into the streams will not cause eutrophication. The first 
process in the secondary treatment is the aeration basin, which relies on biological 
reactions rather than physical separation like in the primary treatment. Oxygen is brought 
into the tanks to promote the growth of aerobic microbes that consume carbon and 
nitrogen products in the wastewater. The bacterial growth is then collected as flocculated 
mass and removed. Then, water travels to the secondary clarification treatment process, 
which is like the primary one. The secondary clarification treatment removes the solids to 
be used in other processes or to send them back to the aeration basin process. After that, 
water goes to further treatment, often using membrane filters to purify the water. This 
technique forcing water through very small pores sized filters to get rid of very fine 
particles and microorganisms (7) . 
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The final stage is using couples of different techniques depending on the 
wastewater treatment plants. It is known as disinfection treatment. The main goal of this 
treatment is to remove any remaining bacteria or other microorganisms.  Chlorine 
disinfection is one of the most widely used mothed but ultraviolet technique is more 
efficient. Ozonation technique is also a widely used for this process. The purpose of all of 
them is to ensure that the water is free from any remaining microorganisms that may 
cause diseases. Now, the water is clean and free to go and can be returned to environment 
(8) .  
Antibiotic resistance and beta-lactams 
Antibiotic resistance has a major impact on human health. It becomes a real threat 
to humanity in recent decades due to the growth of a large number of resistant 
microorganisms. Bacteria have evolved to survive in many environments and can develop 
mechanisms to withstand the action of antibacterial agents in a short amount of time (9) 
( 1 0) .  Since the discovery by Alexander Fleming in the 1 920s, the penicillin group of 
drugs became very widely used to treat bacterial infections . Penicillin is a member of the 
class of antibiotic compounds known as beta-lactams. In the recent years, beta-lactam 
antibiotic has become the most commonly used antibiotic. Beta-lactams is taking the 
majority of prescriptions for injectable antibiotics by 65% in United States ( 1 1 )  (Figure 
1 ) . The most common forms of beta-lactam drugs are penicillins, cephalosporins, and 
monobactams. These drugs are prescribed to cure bacterial infections, such as diarrhea, 
hypersensitivity, nausea, rash, neurotoxicity, urticaria, and other infections (12). 
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1%0% 
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• polymyxins 
Figure 1 .  The percentage of standard units for each injectable antibiotic prescribed in the 
United States from 2004 to 20 1 4. (Data from the IMS MDART Quarterly Database on 
file at AstraZeneca.) . ( 1 1 )  
The structure of most bacteria consists of cell membrane surrounded by cell wall. 
The bacterial cell wall is a flexible macromolecule protecting the bacterium, enabling it 
to resist lysis caused by high intracellular osmotic pressure. Bacterial cell walls are made 
of glycan strands linked together to obtain a polymer called peptidoglycan. Peptidoglycan 
consists of two alternating saccharides, N-acetyl glucosamine (GlcNAc, NAG) and N-
acetyl muramic acid (MurNA, NAM). These two components are cross-linked by short 
chains of amino acids. In the process of cross-linking of the amino acid chains, two 
enzymes are involved in this process: D-alanyl carboxypeptidase and transpeptidase. 
These are sometimes known as penicillin binding proteins (PBPs), and they are the target 
for beta-lactam antibiotics ( 1 3) ( 1 4) .  Beta-lactams are chemicals that contain the beta-
lactam ring structure that is essential for disabling cell wall crosslinking in bacteria. The 
function of beta-lactam antibiotics is to bind the PBPs that cross-link peptidoglycan and 
prevent the bacterial cell wall synthesis. Thus, the cell wall becomes weakened and 
13 
breaks easily due to high intracellular osmotic pressure (Fig.2) ( 1 5) .  
Figure 2. Beta-lactam drug in action ( 1 6) .  
Beta-lactamases 
Since beta-lactam class drugs are prescribed in high frequency and used routinely 
as first-line antibiotic for infectious diseases, resistance to beta-lactam class drugs poses a 
significant challenge to human health. Beta-lactamase (bla) was discovered in the 1 940s 
even before the clinical use of penicillin. It was identified in Escherichia coli by E.P. 
Abraham and E. Chain, and named as "penicillinase." The enzyme was not considered to 
be clinically relevant at the time. Initially, Abraham and Chain were unable to isolate the 
enzyme in vitro. After four years, Kirby was the first scientist who extracted these cell­
free "penicillin inactivators" from Staphylococcus aureus, which is a significant 
opportunistic pathogen ( 1 7) .  
Beta-lactamase i s  a group of  enzymes produced by various bacterial cells to 
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inactivate beta-lactam antibiotics by destroying the beta-lactam ring structure. It is 
considered one of the major causes for resistance to large valuable selections of 
antibacterial agents. There are more than 1,300 beta-lactamases occurring naturally, 
which make them perhaps one of the largest enzyme families that has been studied. In 
many clinical treatment regimes, beta-lactam class of antibiotics, such as cephalosporins 
and carbapenems, are used to treat serious infections. The ability ofbeta-lactamases to 
inactivate this large array of antibiotics makes them a real threat to public health. ( 1 8) 
Bacteria can become resistant to beta-lactam antibiotics by using one of four 
primary mechanisms ( 1 5). First, bacteria can produce beta-lactamase enzymes. It is very 
common and important mechanism of resistance especially in Gram-negative bacteria. 
Second, changes can occur in the active site of PBPs, which can lower the affinity for 
beta-lactam antibiotics. Third, bacteria can decrease the expression of outer membrane 
proteins (OMPs). Finally, efflux pumps can prevent beta-lactam antibiotics to enter the 
cell or throw them out of the cell, which help the bacteria to become multidrug 
resistant. ( 1 7) 
Related to the wastewater spreading ofbeta-lactamases issue, there are three 
known mechanisms to transfer a resistant gene into bacterial cell. Since the bacteria are 
swimming in the water, it is possible to receive a resistant gene by conjugation facilitated 
by F '  factors, transformative uptake of chromosomal DNA fragments or plasmids, or 
transduction mediated by phages (Fig. 3 ). Once the gene is received and integrated, the 
bacterium can produce beta-lactamase and becomes resistant to beta-lactam drugs. In 
addition, since the wastewater sample is released back into the environment, if the 
resistant variants can persist throughout the treatment, it will then travel with water to 
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other hosts, which can be in this case humans (19). 
Figure 3. Three primary mechanisms to transfer a resistant gene into bacterial cell.( 1 5) 
Beta-lactamase classification 
The most common scheme for classification of beta-lactamases was developed by 
Bush and Medeiros ( 1 995). Bush's classification is based on the molecular structure of 
the enzymes and earlier schemes. Another famous and widely used classification 
introduced by Ambler ( 1 99 1 ) . Ambler classification based on conserved and 
distinguishing amino acid motifs. Table 1 included both Ambler' s  and Bush's  
classifications. (20, 21) 
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Table 1. Beta-lactamase classification systems by both Ambler and Bush.(20, 2 1 )  
Ambler Bush Characteristics of beta-lactamases Number 
class group of 
enzymes 
A 2a Staphylococcal and enterococcal penicillinases 23 
2b Broad spectrum beta-lactamases including TEM-1 and SHV-1, usually 16 
occurring in gram-negatives bacteria 
2be Extended spectrum beta-lactamases (ESBL) 200 
2br Inhibitor-resistant TEM (IRT) beta-lactamases 24 
2c Carbenicillin-hydrolysing enzymes 19 
2d Cloxacillin (oxacillin) hydrolyzing enzymes 31 
2e Cephalosporinases inhibited by clavulanic acid 20 
2f Carbapenem-hydrolysing enzyme inhibited by clavulanic acid 4 
B 3 Metallo-enzymes that hydrolyse carbapenems and other beta- 24 
lactamases except monobactams. Not inhibited by clavulanic acid 
c 1 Usually chromosomal enzymes in gram-negatives but some are 51 
Plasmid-coded. Not inhibited by clavulanic acid 
D 4 Miscellaneous enzymes that do not match any of the previous 9 
characteristics in the other groups 
The real function ofbeta-lactamases is to destroy the beta-lactam ring. Thus, beta-
lactam antibiotic components are no longer active to attack PBPs proteins. However, 
some gram-negative bacteria produce very powerful beta-lactamases called extended 
spectrum beta-lactamases (ESBLs). ESBLs hydrolyze large groups ofbeta-lactam 
antibiotics, such as penicillins, cephalosporins, and monobactams (22). 
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PCR for environmental samples 
The detection of antibiotic resistant genes that exist in the environment recently 
relies on PCR analysis of purified DNA from environmental samples, such as soil, 
wastewater, or untreated water (23-25) .  The need of a rapid technology to detect and 
identify pathogen genotypes and resistance genes resulted in the developing of many 
different PCR-based methods. Also, the slowness and the lack of sensitivity in standard 
laboratory methods may result in inefficient and unreliable data. For Example, screening 
of intestinal carriers ofbeta-lactamase producing bacteria, which usually uses selective 
agar plates in standard laboratory methods, has a lower sensitivity compared to PCR­
based methods. In recent studies, PCR-based methods become efficient due to their 
sensitivity. Another example, a clinical study showed that a real-time PCR created to 
detect blaKPC in rectal swabs proved a sensitivity of 97%, whereas CHROMagar plates 
were only 77% (26). 
For environmental samples, many studies suggested using standard PCR 
amplifications as a first method in the molecular examination after the successful 
extraction of the DNA to detect either bacterial or beta-lactamase enzymes. The single 
end-point PCR works on amplifying a target gene with the existence of specific primers . 
Thus, it can be seen and investigated using agarose gel electrophoresis method ( 1 0). 
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Study objectives 
The aim of this study was to examine the presence ofbeta-lactamase genes in 
wastewater and untreated stream water samples. Two different stages in the wastewater 
treatment process were analyzed. Untreated stream water sampled at locations both 
upstream and downstream of the wastewater plant efflux point were also examined. 
Using appropriate negative and positive controls, the presence of several variants ofbeta­
lactamase ( bla) will be detected using PCR. 
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Methods and materials 
Samples collection 
Total of 6 samples were collected. 4 samples were collected from Charleston 
Wastewater Treatment Plant (CWWTP) in Charleston, Illinois. Influx samples 1000 mL 
(samples after the head clearing and before the primary clarification) and Efflux 2000 mL 
(right before the release into Cassell creek) were collected. Also, two untreated water 
samples were collected from the bottom of Cassell creek. First untreated water sample 
2000 mL was collected from upstream from CWWTP (39°29'55 .0"N 88° 12' 19 .3"W). 2nd 
sample 2000 mL was collected from downstream from CWWTP (39°29' 16 .5"N 
88° 12'34.2"W) (Fig. 4) . In all cases, samples were collected in sterile bottles and 
transported on ice for processing within four hours. 
Figure 4 .  sites of samples collection obtained from google maps. 
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T bl 2 S a e . 1 d t fr amp es a a  om b h (CWWTP) d C ot an asse ll k cree 
� 
Samples from Charleston wastewater treatment plant Untreated water 
F (CWWTP) from Cassell creek 
Sample's No. Sample I Sample2 Sample3 Sample4 Sample5 Sample6 
Date 1/31/2017 2/16/2017 3/03/2017 3/29/2017 4/17/2017 4/17/2017 
site Influx Efflux Influx Efflux Influx downstream Influx Efflux Upstream downstream 
volume l!OOmL 2000mL IOOOmL 2000mL 2000mL IOOOmL IOOOmL 2000mL IOOOmL IOOOmL 
Filtration IOOmL YES NO YES IOOmL YES NO YES SOOmL YES 
Centrifugation YES NO YES NO YES NO YES NO SOOmL NO 
Processing procedures 
• Filtration 
Samples ware filtered using sterile 47-mm diameter nitrocellulose filters 
(NALGENE®Nalge Nunc International, USA) with pore size of 0.22 µm. For sample 1 ,  
samples were collected from wash solution of sterile water after discs were submerged 
and scraped with sterile spatula. For the other samples, filter discs were cut up into small 
pieces using sterile scalpel blades. 
• Centrifugation 
1 000 mL from each sample were divided into 4 centrifuge sterile bottles (250 mL 
each) . Only sample 1 influx samples were centrifuged at 44 72 x g for 1 5  minutes (Sorvall 
RC-5B Superspeed Centrifuge) . The other influx samples were centrifuged at 1 5 ,000 x g 
for 20 minutes. Then, Supernatant was removed and solid leftover was mixed in one 
bottle then transferred to 1 .5 mL microcentrifuge tubes, which were then centrifuged at 
1 7,000 x g for 20 minutes. After that, supernatant liquid discarded and solids were 
combined to reduce the total number of the tubes for the next procedure. 
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• Bead beating and E. coli controls 
Solids and filter discs were divided into multiple bead beating tubes provided with 
DNA extraction kits . Sample 1 were bead beating followed the time suggested by 
manufacture ' s  instruction of ZR-Duet TM DNA/RNA mini prep plus (Zymo Reaserch, 
USA) . Time variations of bead beating and cultured E. coli supplement for sample 2 to 
sample 4 are shown in the Table 3 .  Samples 2 and 3 were used in bead beating tubes 
provided with ZR fecal DNA mini prep ™ kit (Zymo Research, USA). Samples 4, 5, and 
6 were used in bead beating tubes provided with Fast DNA R spin kit for soil (MP 
Biomedicals, USA) . Mini-Beadbeater-16 (BioSpace Products, USA) machine was used in 
this process. 
Table 3. Bead beating time variation and E. coli supplement for wastewater samples 2-4. 
� 
Bead beating tubes Bead beating time E. coli supplement (CFU 
labeled as variation per each tube > 1 x 1010 per mL) LP 
Sample 2 12(a) 3 mins -
influx 12(b) 5 mins -
12(c) 1 0  mins -
Sample 2 E2(a) 3 mins -
efflux E2(b) 5 mins -
E2(c) 1 0  mins -
Sample 3 B (a) followed manufacture ' s  -
influx instruction 
B (b) followed manufacture ' s  500µL was added 
instruction 
B (c) followed manufacture' s  -
instruction 
B (d) 5 mins 750µL was added 
13 (e) 5 mins -
13 (±) 1 5  mins -
B (g) 1 5  mins 750µL was added 
B (h) 2 mins -
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13(i) 5 mins -
BG) 1 0  mins -
13(k) 1 5  mins -
Sample 3 E3(a) followed manufacture's -
efflux instruction. 
E3(b) followed manufacture's 500µL was added 
instruction. 
Sample 4 14(a) 30 sec 250µL was added 
influx 14(b) 30 sec -
14(c) 90 sec -
14(d) 1 80 sec -
Sample 4 E4(a) 30 sec 250µL was added 
efflux E4(b) 30 sec -
E4(c) 90 sec -
E4(d) 1 80 sec -
Genomic DNA extraction 
Following bead-beating, all samples were processed following manufacturers' 
protocols according to each respective extraction kit. The total volume of eluted DNA 
was 1 00 µL from each single bead beating tube. Samples 4 to 6 were further cleaned up 
using GeneClean II kit (MP Biomedicals, USA) . 
Quantification 
Extracted DNA from the samples were quantified using Epoch™ 2 Microplate 
Spectrophotometer (BioTek, USA). We used 2 µL from the samples for all quantification 
tests . Gen5 software was used for this procedure. 
PCR reactions 
For amplification of the specific DNA sequences, Biometra T-Gradient Thermal 
Cycler PCR (Gottingen, Germany) and BioRad MyCycler PCR (Hercules, USA) systems 
were used in all PCR reactions. Different primers sets were used to amplify the selected 
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genes. Bacteria genes were first detected by universal 1 6S rDNA fragments. The long set 
of primers were 47F and 1 492R and the short set were 47F and 069 1 R  primers (Table 4) . 
Primers for bla loci are listed in Table 5 .  All reactions were carried out using Taq 2X 
Master Mix (New England Biolab, USA) following the manufacturer's protocols. Each 
primer was added at 1 0  pmol per reaction. PCR cycles and conditions are shown in 
Tables 6 & 7. 
Table 4. 1 6S universal primers used in this study and their sequences. 
Primer Sequence (5'-3') 
47F C GAGTTTGATCCTGGCTCAG 
1492R GGTTACCTTGTTACGACTT 
069 1 R  GCATTACARGATTTCAC 
Table 5. bla primers used in this study and their sequences. 
Primer Sequence (5'-3') Gene ID number Reference 
bfaKPC For: ATGTCACTGTATCGCCGTC 1 39 1 40 1 5  (27) 
Rev: TTACTGCCCGTT AACGCC 
blasHV For: ATTTGTCGCTTCTTTACTCGC 63841 72 (27) 
Rev: TTTATGGCGTTACCTTTGACC 
bfaTEM For: AGACGTCAGGTGGCACTTTTCGG 1 238792 (27) 
Rev: CAAGGGGTCTGACGCTCA 
bfaAmpCR For: ATCAAAACTGGCAGCCG 
Rev: GAGCCCGTTTT ATGGACCCA 
5850688 (27) 
Table 6. PCR conditions and time for 1 6S rDNA amplifications. 
!� Condition and time Initial denaturation Melting Annealing Extension Final Hold (0c) (°c)/Time (°c)/Time (°c)/Time (°c)/Time extension s r (°c)/Time 
47F 96° I 5 mins 96° I 30 49° 120 72° I lmin 720 14 40 
1 492R (long) sec x35 sec x35 20sec x35 mins 
47F 96° I 5 mins 96° I 30 48° 120 72° /35 sec 72° /1 min 40 
069 1 R  (short) sec x35 sec x35 x35 30 sec 
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Table 7. PCR conditions and time for bla genes amplifications. 
I� Condition and time Initial denaturation Melting Annealing Extension Final Hold (0c) (0c)ffime (0c)ffime (0c)ffime (0c)ffime extension s r (°c)ffime 
bfaKPC 94° I 1 min 94° I 30 59.5°130 72°/30 sec 72°/10 40 
bfaTEM sec x30 sec x30 20sec x30 mins 
blasHV 94° I 1 min 94° I 30 56°130 72° 130 sec 72°110 40 
bfaArnpCR sec x30 sec x30 x30 mins 
Table 8. PCR compositions. 
Component 25 11L reactions 
Taq 2X Master Mix 12 .5  µL 
1 0  pmol per forward pritµer 1 µL 
1 0  pmol per reverse primer 1 µL 
DNA sample 0 .5-1 0 .5  µL 
Nuclease-free water To 25 µL 
Agarose Gel Electrophoresis 
Agarose gels (0 .8% or 1 .4% (w/v)) were prepared in l x  TBE buffer supplemented 
with GelRed. Electrophoresis was conducted at 95- 1 1 0 m V for 1 -3 hours. Results were 
viewed with UV illumination, photographed using a Gel Doc XR+ system, then analyzed 
by Image Lab 3.0 software (BioRad Laboratories, Inc. ,  Hercules, CA, USA) . 
Controls 
Purified E. coli strain ATCC 25922 DNA used as a positive control for all 1 6S 
rDNA PCR reactions. Positive controls for bla variants were obtained from BEI 
Resources (Table 9). 
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Table 9. Positive control strains for bla variants. 
Strain Description Reference 
NR-1 6465 Klebsiella pneumoniae isolate 2 (27) 
NR-1 5466 Klebsiella pneumoniae isolate 3 (27) 
NR-1 5470 Klebsiella pneumoniae isolate 7 (27) 
NR-1 5471 Klebsiella pneumoniae isolate 8 (27) 
NR-1 6465 Klebsiella pneumoniae isolate 1 (27) 
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Results 
I. DNA extraction 
Water samples were collected and processed as described in Methods and 
Material before different extraction kits were used to obtain total DNA. Three different 
kits were used: Duet DNA/RNA miniprep and Fecal mini prep from Zymo Research, 
and Fast DNA Spinkit for Soil miniprep from MP Biomedicals. All three kits employ 
bead-beating as method of liberating DNA from environmental samples. Varying 
durations of beating were tested in each kit (see Table 3) to assess the impact on DNA 
purification. Further, to control for the ability of the kits to obtain bacterial DNA, stock 
E. coli solutions were added to select samples prior to processing. Following purification 
with the MP Fast DNA Spinkit, samples were further purified using GeneClean II system 
from MP Biomedicals to remove putative chemical inhibitors for PCR reactions (see part 
II ofresults) . DNA samples were then quantified as described (Table 1 0) .  The 260/280 
ratio was also obtained to assess the purity of the DNA samples. 
In general, influx samples yielded higher amounts of total DNA. The duration of 
bead-beating did not make significant changes in the quantity of DNA retrieved, nor did 
it make a significant change in the purity ratio .  
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Table 10. Quantification of wastewater and untreated fresh water samples. 
I� 
tubes labeled DNA 2601280 ratio Chromosomal 
as concentration DNA Integrity s 
(mglnL) 
Sample 1 I 1  205.742 1 . 884 NIA 
influx 
Sample 1 E l (a) 74.675 1 . 869 NIA 
efflux E l (b) 1 6 .267 1 .768 NIA 
Sample 2 I2(a) 1 82 .869 1 .443 Good 
influx I2(b) 93.974 1 . 1 29 Good 
I2(c) 83.993 1 .302 Good 
Sample 2 E2(a) 9 .64 1  1 .208 Very poor 
efflux E2(b) 6 .708 1 .472 Very poor 
E2(c) 4.027 1 .231 Very poor 
Sample 3 I3(a) 1 1 .295 1 .2 1 9  Very poor 
influx I3(b) 8 .667 1 .435 Very poor 
I3(c) 8 .541  1 .244 Very poor 
I3(d) 25 .077 1 .563 Poor 
I3(e) 3.098 1 .524 Very poor 
I3(f) 5 .666 1 .524 Very poor 
I3(g) 24. 1 9 1  1 .635 Poor 
I3(h) 28 .546 1 .707 Poor 
I3(i) 30.49 1 1 .559 Poor 
BG) 1 1 .254 1 .671 Very poor 
I3(k) 1 3.748 1 .602 Very poor 
Sample 3 E3(a) 6 .9 1 6  1 .386 Very poor 
efflux E3(b) 9 .0 1 5  1 .7 17  Very poor 
Sample 4 I4(a) 7.4 1 3  5 .38 1 Good 
influx I4(b) 8 .466 3.558 Good 
I4(c) 9.526 3 .583 Good 
I4(d) 1 2 . 1 72 4. 1 32 Good 
Sample 4 E4(a) 1 . 873 -1 7  Good 
efflux E4(b) 8 .972 4.765 Good 
E4(c) 2.299 5 .25 Good 
E4(d) 1 3.923 2 .608 Good 
Sample 5 U5(a) 2 1 . 1 86 2 . 1 1 5  Good 
Upstream U5(b) 1 8 .422 3. 1 42 Good 
Sample 6 D6 32 .497 2 .28 1 Good 
downstream 
In addition to the 2601280 ratio, which reveals the amount of protein carry over in 
the DNA preparation, the quality of the total DNA samples were also assessed using 
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agarose gel electrophoresis.  The gel images reveal the extent of breakage of the DNA 
samples (Figures 5 to 1 0) . The MP DNA Fastspin soil kit provided DNA samples of high 
molecular weight, indicating that shearing and breaking of chromosomal sample was 
much reduced compared to either of the two kits from Zymo Research. 
Figure 5. Chromosomal DNA integrity for sample 2 using ZR-Duet™ 
DNNRNA mini prep plus kit (Zymo Reaserch, USA) with differences in 
bead beating times (E2(a) and I2(a) = 3 mins, E2(b) and I2(b) = 5 mins, 
E2(c) and I2(c) = 10 mins) . 
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Influx 
Figure 6. Chromosomal DNA integrity for sample 3 using ZR fecal DNA mini prep TM 
kit. C l  and C2 are E. coli that were extracted using ZR fecal DNA mini prep TM kit with 
different in bead beating times (I3 (a), I3 (b), I3 (c), E3(a) and E3(b) followed 
manufacture's instruction) . (13(d), 13 (e) ,  13(i), and C l= 5 mins) . (13 (h) = 2 mins) . (BG) = 
1 0  mins) . (I3 (f), 13 (g), I3 (k) and C2 = 1 5  mins) . C3 is purified E. coli DNA. I3 (b) and 
E3(b) 500µL of E. coli solutions were added to each bead beating tube before DNA 
extraction. I3 (d) and 13 (g) 750µL of E. coli solutions were added to each bead beating 
tube before DNA extraction. L is a ladder (2 log ladder) . 
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Figure 7. Chromosomal DNA integrity for E. coli controls extracted by both ZR fecal 
DNA mini prep ™ kit (Zymo Research, USA) and Fast DNA R spin kit for soil (MP 
Biomedicals, USA) with variation bead beating times (C l and CS = 30 sec, C2 and C6 
= 
60 sec, C3=90 sec, C4= 1 20 sec) . L is a ladder (2 log ladder) . 
3 1  
I 
MP kit 
Figure 8. Chromosomal DNA integrity for E. coli controls after using GeneClean II kit 
(MP Biomedicals, USA) . E. coli controls were extracted by both ZR fecal DNA mini 
prep TM kit (Zymo Research, USA) and Fast DNA R spin kit for soil (MP Biomedicals, 
USA) with variation bead beating times. C l  and CS = 30 sec, C2 and C6 = 60 sec, C3=90 
sec, C4=1 20 sec) . L is a ladder (2 log ladder) . 
3 2  
Efiflux 
L 
�gure 9. Chromosomal DNA integrity for sample 4 using Fast DNA R lpin kit for soil 
and further cleaned up using GeneClean II kit with variation in beadf beating times (I4(a) ,  
I4(b), E4(a) ,  and E4(b) = 30 sec), (I4(c) and E4(c) = 90 sec), (I4(d) and E4(d) = 1 80 sec) . 
I4(a) and E4(a) 250µL of E. coli solutions were added to the bead beatiig tube before 
DNA extraction. L is a ladder (2 log ladder) . . 
I i' I 
33 
Figure 10.  Chromosomal DNA integrity for Samples 5 and 6 using Fasf DNA R spin kit 
for soil and further cleaned up using GeneClean II kit. L is a ladder (2 log ladder) . U5 is 
upstream sample no. 5 .  (a) is 500mL filtered. (b) is 500mL centrifuged. D6 is 
downstream sample no. 6 .  
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In summary, the quality of DNA extraction varied significantly between the 
extraction methods used. The Duet DNA/RNA kit and Fecal Sample Kit from Zymo , 1 1 Research produced DNA samples that are low in molecular weight. The MP Fast DNA 
Spin Kit for Soil provided DNA samples with high molecular weight. le purity of the 
samples varied but appeared to be dependent on sample source rather tlian on either 
extraction kit employed or beating time. 
II. PCR results 
Detection of bacterial 1 6S rDNA 
Since both wastewater and freshwater samples can contain orgahisms other than 
I 
bacteria, the presence of total DNA of good quality is not sufficient indication that they 
are suitable for PCR-based essay for bacterial genes. Therefore, as a cottrol to show that 
DNA samples we extracted contain bacterial chromosomal DNA, the 1 6S rDNA 
universal primers were used. Two versions of the 1 6S fragment were usled as control 
reactions for the presence of bacterial samples (Figures 1 1  to 1 7) .  Successful 
amplification of either of the two 1 6S fragments indicates that there are [detectable levels 
of bacterial chromosomes in the extracted total DNA of a particular preParation. 
The range of failed PCR amplification for 1 6S fragments in certain extraction 
methods (Figures 1 1  to 1 2) led to the addition of the positive control E. !coli DNA to the 
environmental DNA samples (lanes b2 and k2 in Figures 1 3  and 1 4, and also marked lane 
in Figure 1 5) .  The results showed that the same amount and type of DNf that can 
produce successful 1 6S amplification on its own did not lead to detectable PCR products 
when added to the environmental DNA samples extracted using either the ZR-Duet 
� I 
DNA/RNA miniprep or the Fecal DNA Sample miniprep kit. 
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Figure 11 .  Long (PsL) and short (PsS) sets of 1 6S rDNA primers results for sample 1 .  
Cl  and C2 are E. coli positive controls. L i s  a ladder (2 log ladder) . 
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Figure 12.  Long set of 1 6S rDNA primer results for sample 2 using ZR-Duet™ 
DNA/RNA mini prep plus kit (Zymo Research, USA) with differences in bead beating 
times (E2(a) and 12(a) = 3 mins, E2(b) and 12(b) = 5 mins, E2(c) and 12(c) = 1 0  mins) . 
C is E. coli positive control . L is a ladder (2 log ladder) . 
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Influx 
Figure 13. Long set of l 6S rDNA primers results for sample 3. (b )2 is DNA plus E. coli 
purified DNA after extraction before PCR reaction. (k)2 is sample DNA plus E. coli 
purified DNA after extraction before PCR reaction. C l  and C2 are E. coli that were 
extracted using ZR fecal DNA mini prep ™ kit with different bead beapng times (13 (a), 
I3(b), I3(c) ,  E3(a) and E3(b) followed manufacture ' s  instruction) .  (I3 (d), I3 (e), I3(i), and 
C l =  5 mins) . (13 (h) = 2 mins) . (BG) = 1 0  mins) . (13 (t), 13 (g), 13 (k) an� C2 = 1 5  mins) . 
C3 is E. coli positive control .  L is a ladder (2 log ladder) . 
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Figure 14. Short set of l 6S rDNA primers results for sample 2 .  (b )2 is DNA plus E. coli 
purified DNA after extraction before PCR reaction. (k)2 is sample DNA plus E. coli 
purified DNA after extraction before PCR reaction. C l  and C2 are E. coli that were 
extracted using ZR fecal DNA mini prep TM kit with different bead beating times (B (a) ,  
B(b), B (c), E3(a) and E3(b) followed manufacture ' s  instruction). (B(d), B(e), B(i), and 
C l = 5 mins) . (B(h) = 2 mins) . (B G) = 10 mins) . (I3 (f), I3 (g), I3 (k) and C2 = 15 mins) . 
C3 is E. coli positive control. L is a ladder (2 log ladder) . 
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644 bp 
M P  kit 
Figure 15. Short set of 1 6S rDNA primers results for E. coli controls extracted by both 
ZR fecal DNA mini prep ™ kit and Fast DNA R spin kit for soil with variation bead 
beating times (C l and CS = 30 sec, C2 and C6 = 60 sec, C3=90 sec, C4=120 sec) . C2 + 
E. coli CS + E. coli are E. coli purified DNA added to the samples after extraction before 
PCR reactions. L is a ladder (2 log ladder) . 
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644 bp 
100 bp 
Figure 16. Short set o f  1 6S rDNA primers results for sample 4 using Fast DNA R spin kit 
for soil and further cleaned up using GeneClean II kit with variation in bead beating 
times (I4(a), I4(b), E4(a) ,  and E4(b) = 30  sec), (I4(c) and E4(c) = 90 sec), (I4(d) and 
E4(d) = 1 80 sec) . I4(a) and E4(a) 250µL of E. coli solutions were added to the bead 
beating tube before DNA extraction. L is a ladder (2 log ladder) . P is E. coli positive 
control. 
· 
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Figure 17. Short set of 1 6S rDNA primers results for sample 5 and 6 using Fast DNA R 
spin kit for soil and further cleaned up using GeneClean II kit. L is a ladder (2 log 
ladder) .  U5 is upstream sample no. 5. (a) is 500mL filtered. (b) is 500mL centrifuged. D6 
is downstream sample no . 6 .  P is E. coli positive control. 
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Detection of bla variants 
Detection of bla variants were carried out as described in Methods and Material, 
with positive control DNA obtained from the BEI Resource Center. The four variants of 
bla were each assayed in separate PCR reactions using samples from extractions 4, 5, and 
6. Extraction 4 was performed on wastewater samples, whereas extractions 5 and 6 were 
from freshwater gathered upstream and downstream, respectively, from the wastewater 
plant efflux site. All three samples showed positive outcomes for the 1 6S confirmation of 
bacterial DNA. 
For variants blaKPc and b/asHV, all four wastewater influx samples from sampling 
number 4 gave rise to positive amplification products, whereas none of the efflux or 
stream water samples sho"'."ed positive outcomes (Figures 1 8  and 20) . For variant blarnM, 
two of the four wastewater samples showed a positive amplification while none of the 
influx or stream water samples did (Figure 1 9) . . For variant blaAmpeR, the outcomes were 
difficult to decipher because the bands produced by environmental samples did not match 
the size of the positive control band (Figure 2 1 ) . Further, the negative control E. coli 
DNA produced a band that is repeated in the environmental samples, including one of the 
efflux samples. This suggested that the bands observed might be an artifact of non­
specific reactions during PCR. 
The PCR results of both the 1 6S rDNA and bla loci are summarized in Table 1 1 . 
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Figure 18.  blaKPc PCR products for sample 4 ,  5 and 6.  N is E. coli negative control. P is 
Klebsiella pneumoniae positive control .  L is a ladder (2 log ladder) . The differences are 
in bead beating times (14(a), 14(b), E4(a), and E4(b) = 30 sec), (14(c) and E4(c) = 90 
sec), (14(d) and E4(d) = 1 80 sec) . 14(a) and E4(a) 250µL of E. coli solutions were added 
to the bead beating tube before DNA extraction. US is upstream sample no. 5 .  (a) is 
500mL filtered. (b) is 500mL centrifuged. D6 is downstream sample no. 6. 
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Figure 19. blaTEM PCR products for sample 4, 5 and 6.  N is E. coli negative control. P is 
Klebsiella pneumoniae positive control. L is a ladder (2 log ladder) . The differences are 
in bead beating times (14(a), 14(b), E4(a),  and E4(b) = 30 sec), (14(c) and E4(c) = 90 
sec), (14(d) and E4(d) = 1 80 sec) . 14(a) and E4(a) 250µL of E. coli solutions were added 
to the bead beating tube before DNA extraction. US is upstream sample no. 5 .  (a) is 
SOOmL filtered. (b) is SOOmL centrifuged. D6 is downstream sample no. 6. 
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Figure 20. blasHV PCR products for sample 4, 5 and 6.  N is E. coli negative control .  P is 
Klebsiella pneumoniae positive control. L is a ladder (2 log ladder) . The differences are 
in bead beating times (14(a), 14(b), E4(a) ,  and E4(b) = 30 sec), (14(c) and E4(c) = 90 
sec), (14(d) and E4(d) = 1 80 sec) . 14(a) and E4(a) 250µL of E. coli solutions were added 
to the bead beating tube before DNA extraction. US is upstream sample no. 5 .  (a) is 
500mL filtered. (b) is 500mL centrifuged. D6 is downstream sample no. 6. 
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Figure 21 .  blaAmpeR PCR products for sample 4, 5 and 6. N is E. coli negative control .  P 
is Klebsiella pneumoniae positive control. L is a ladder (2 log ladder) . The differences 
are in bead beating times (14(a), 14(b), E4(a), and E4(b) = 3 0  sec), (14(c) and E4(c) = 90 
sec), (14(d) and E4(d) = 1 80 sec) . 14(a) and E4(a) 250µL of E. coli solutions were added 
to the bead beating tube before DNA extraction. US is upstream sample no. 5 .  (a) is 
500mL filtered. (b) is 500mL centrifuged. D6 is downstream sample no. 6. 
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Table 1 1. Summary of PCR results . 
Info tubes 
Sa les labeled 
as 
Sample 1 I 1  
influx 
Sample 1 E l (a) 
effiux El (b) 
Sample 2 12(a) 
influx 12(b) 
12(c) 
Sample 2 E2(a) 
effiux E2(b) 
E2(c) 
Sample 3 B (a) 
influx 13 (b) 
B (c) 
13 (d) 
13 (e) 
B (f) 
13 (g) 
13 (h) 
13 (i) 
13 (i) 
13 (k) 
Sample 3 E3(a) 
effiux E3(b) 
Sample 4 14(a) 
influx 14(b) 
14(c) 
14(d) 
Sample 4 E4(a) 
effiux E4(b) 
E4(c) 
E4(d) 
Sample 5 U5(a) 
Upstream U5(b) 
Sample 6 D6 
downstream 
E. coli c 
(control) 
Klebsiella p 
pneumoniae 
16S rDNA results 
47F 
1492R 
(Long) 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- . 
-
-
-
-
-
-
-
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
+ 
+ 
47F 
0691R 
(Short) 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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Bia loci results 
b/aK.PC b/aTEM blasHV b/aAmpCR 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
NIA NIA NIA NIA 
+ - + +I-
+ + + +I-
+ + + +I-
+ - + +I-
- - - +I-
- - - -
- - - -
- - - -
- - - -
- - - -
- - - -
- - - +I-
+ + + + 
Discussion 
I. Extraction of bacterial DNA quality varies by method 
Different commercial kits that were used to extract DNA from environmental 
sources may play a major impact on the quality of DNA. In this study, we used different 
types of kits to extract DNA from water samples. Based on the results, bacterial DNA 
that were extracted form samples 1 and 2 using ZR-Duet TM DNA/RNA mini prep plus 
kit gave us good DNA concentrations (Table 9) but they were not able to amplify 1 6S 
rDNA fragments (Figures 1 1  and 1 2) .  It may be a result of the type of DNA extracted not 
belonging to bacterial cells or the DNA was shredded and broken into small pieces. 
Similar results were observed with sample 3 using ZR fecal DNA mini prep TM kit. While 
the 2_60/280 ratio indicated presence of relatively clean preparations from all 3 rounds of 
preparation, the examination of samples on agarose gel showed that the total DNA were 
of low molecular weight, meaning that the samples have been sheared and broken. This 
probably contributed to the inability to amplify 1 6S rDNA products from the samples. 
Furthermore, when E. coli DNA was added to extracted samples as template for 
PCR, no positive outcomes were detected, even though identical E. coli DNA in its 
separate tube gave positive PCR outcomes. This result demonstrated that the two 
extraction kits allowed PCR inhibitors to be carried through the samples during 
process mg. 
In contrast, extraction using MP Fast DNA for Soil kit followed by GeneCleanll 
purification led to 260/280 ratios that indicated presence of protein contamination, but 
provided chromosomal DNA of high molecular weight and which allowed for successful 
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amplification of 1 6S rDNA control fragments. This result showed that the purification 
process managed to remove PCR-inhibiting compounds from the samples that the two 
other kits left behind. 
For all three DNA extraction kits examined, the duration of bead-beating did not 
seem to make a significant difference in the outcome. In all cases, lengthening the 
duration did not cause any observable changes in the quality of DNA samples and had no 
measurable impacts on the success of PCR amplifications. 
II. Presence of bla variant loci in water samples 
Using DNA samples that provided positive outcomes for 1 6S rDNA control 
fragments, the presence of bla variant loci was examined. Of the four variant loci 
examined, three of them showed positive outcomes in the wastewater influx samples, 
demonstrating the presence of these antibiotic resistance loci in the wastewater sample at 
the Charleston wastewater treatment plant. One of the three positive variants, blarnM was 
detected in 2 of the 4 influx samples. The two samples that showed positive amplification 
in this case were vary in beating time than the other two samples. One of the variants 
being assayed, blaAmpcR produced PCR results from environmental samples that did not 
match the band from the positive control, while they did match the band obtained in the 
negative E. coli control. This showed non-specific amplification of this primer set and 
made the results inconclusive. Further testing of PCR conditions for this primer set is 
required. 
The positive outcome of 1 6S rDNA for the efflux and stream water samples 
indicated that the absence of bla amplification products was due to undetectable levels of 
so 
those loci, and not due to the absence of bacterial DNA. The positive control using 
Klebsiella pneumoniae DNA also showed that the primers were working properly. 
Therefore, we conclude that the 3 variant bla loci are not present at detectable level in the 
efflux sample or the stream water samples. 
Since these three bla loci were detected in the influx sample, which was the 
wastewater sample following the head treatment but before primary clarification, but 
absent in the efflux sample, which was the water right before it was discharged into the 
river, we conclude that the water treatment process successfully reduced the level of these 
DNA loci to a level that is below PCR detection. The stream water outcomes also 
demonstrated that these loci are more common in the wastewater influx, and not typically 
present in untreated stream water. 
Although the three loci were no longer detectable at the efflux sample, there is 
still potential hazard in their presence in the influx sample. Throughout the wastewater 
sample processing, solid wastes are removed and treated in different ways; such as being 
used as starting material for anaerobic digester. These resistant loci may still persist in 
those venues. Further examination of the wastewater treatment process will be required to 
fully monitor the potential health risks. Also, this study focused on one sample taken at 
one time during the processing. Therefore, the results should not be generalized to reflect 
the overall status of the quality of the wastewater efflux. A continuous monitoring 
procedure with regular sampling will be required to fully understand the risk of a 
significant presence of these resistant loci in our wastewater efflux samples. In addition, 
there are other variant loci of bla, as well as other antibiotic resistant loci present in 
bacteria, that are also worth investigating in this context. Even though it would be 
5 1  
impossible to monitor all the antibiotic resistant loci at once, a broader capture of loci to 
be examined will greatly enhance the strength of our conclusions regarding the health 
impact. 
5 2  
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